Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
November 8, 2001
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy
J S Blanchet, D Valmori, I Dufau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide
M J Pittet, D E Speiser, D Liénard, et al.
Cancer Research
|
June 30, 2001
Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes
C Pinilla, V Rubio-Godoy, V Dutoit, et al.
La Revue De Medecine Interne
|
August 31, 2014
[Thymic disease associated with nephrotic syndrome: a new case with membranous nephropathy and literature review]
J Seguier, P Guillaume-Jugnot, M Ebbo, et al.
Clinical and Experimental Immunology
|
October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy
M Montes, N Rufer, V Appay, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases
M J Pittet, A Zippelius, D E Speiser, et al.
Cancer Research
|
March 31, 2001
Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires
P Y Dietrich, P R Walker, A L Quiquerez, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells
D E Speiser, M Colonna, M Ayyoub, et al.
European Journal of Immunology
|
February 17, 2001
Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells
D E Speiser, M Migliaccio, M J Pittet, et al.
Journal De Pharmacie De Belgique
|
May 1, 1996
[Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents]
E Differding, M Gillard, N Moguilevsky, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Journal of Immunology (Baltimore, Md. : 1950)
|
November 8, 2001
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy
J S Blanchet, D Valmori, I Dufau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide
M J Pittet, D E Speiser, D Liénard, et al.
Cancer Research
|
June 30, 2001
Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes
C Pinilla, V Rubio-Godoy, V Dutoit, et al.
La Revue De Medecine Interne
|
August 31, 2014
[Thymic disease associated with nephrotic syndrome: a new case with membranous nephropathy and literature review]
J Seguier, P Guillaume-Jugnot, M Ebbo, et al.
Clinical and Experimental Immunology
|
October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapy
M Montes, N Rufer, V Appay, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases
M J Pittet, A Zippelius, D E Speiser, et al.
Cancer Research
|
March 31, 2001
Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptide with diverse and nonoverlapping T-cell receptor repertoires
P Y Dietrich, P R Walker, A L Quiquerez, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 21, 2001
The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells
D E Speiser, M Colonna, M Ayyoub, et al.
European Journal of Immunology
|
February 17, 2001
Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells
D E Speiser, M Migliaccio, M J Pittet, et al.
Journal De Pharmacie De Belgique
|
May 1, 1996
[Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents]
E Differding, M Gillard, N Moguilevsky, et al.
Page
of 10